A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY WITH SUNITINIB IN RECURRENT HIGH-GRADE GLIOMA

被引：0
|
作者：
Wuthrick, Evan [2 ]
Curran, Walter
Lin, Alexander
Glass, Jon [1 ]
Evans, James [2 ]
Andrews, David [2 ]
Axelrod, Rita [2 ]
Pereira-Rico, Alvaro [2 ]
Murphy, Heather
Werner-Wasik, Maria [2 ]
Dicker, Adam [2 ]
机构：
[1] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：885 / 885
页数：1
相关论文
共 50 条
  • [41] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    J. Drappatz
    E. Q. Lee
    S. Hammond
    S. A. Grimm
    A. D. Norden
    R. Beroukhim
    M. Gerard
    D. Schiff
    A. S. Chi
    T. T. Batchelor
    L. M. Doherty
    A. S. Ciampa
    D. C. LaFrankie
    S. Ruland
    S. M. Snodgrass
    J. J. Raizer
    P. Y. Wen
    [J]. Journal of Neuro-Oncology, 2012, 107 : 133 - 138
  • [42] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Gerstner, Elizabeth Robins
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Pulverenti, Julee
    Vardam-Kaur, Trupti
    Stokes, Deirdre
    Smith, Katrina Howard
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Duda, Dan G.
    Jain, Rakesh K.
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    Drappatz, J.
    Lee, E. Q.
    Hammond, S.
    Grimm, S. A.
    Norden, A. D.
    Beroukhim, R.
    Gerard, M.
    Schiff, D.
    Chi, A. S.
    Batchelor, T. T.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Snodgrass, S. M.
    Raizer, J. J.
    Wen, P. Y.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) : 133 - 138
  • [44] Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
    Lee, Eudocia Q.
    Duda, Dan G.
    Muzikansky, Alona
    Gerstner, Elizabeth R.
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew D.
    Doherty, Lisa
    LaFrankie, Debra
    Stefanik, Jennifer
    Vardam, Trupti
    Smith, Katrina H.
    McCluskey, Christine
    Gaffey, Sarah
    Batchelor, Tracy T.
    Jain, Rakesh K.
    Wen, Patrick Y.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4643 - 4649
  • [45] Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-rradiation, Pembrolizumab, and Bevacizumab
    Padmanabhan, R.
    Zhang, G. G.
    Oliver, D. E.
    Graham, J.
    Grass, D.
    Sahebjam, S.
    Yu, H. H. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E596 - E597
  • [46] Phase I trial of arsenic trioxide and fractionated stereotactic radiation for recurrent malignant glioma
    Gibbs, IC
    Harsh, G
    Tupper, L
    Recht, L
    Knox, SJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S158 - S158
  • [47] Salvage Stereotactic Radiosurgery for Recurrent High-Grade Glioma with Prior Radiotherapy
    Costantini, Mary
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 189 - 189
  • [48] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    [J]. Current Treatment Options in Neurology, 2010, 12 : 321 - 333
  • [49] Recurrent High-Grade Glioma
    Quant, Eudocia C.
    Drappatz, Jan
    Wen, Patrick Y.
    Norden, Andrew D.
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (04) : 321 - 333
  • [50] Fractionated Stereotactic Radiation Therapy and Stereotactic Radiosurgery as Salvage Treatment for Recurrent Malignant High-Grade Gliomas
    King, K.
    Blumenfeld, P.
    Shin, J. Y.
    Tolekidis, G.
    Diaz, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E98 - E98
12345